ArticleOcular oncology and pathology2021
Small Choroidal Melanoma: Correlation of Growth Rate with Pathology.
Article in Ocular oncology and pathology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 18 citations in OpenAlex.
- Metastatic potential of small posterior uveal melanomas.Acta ophthalmologica · 2026Article
- The Small Choroidal Melanoma: Diagnosis, Treatment Outcomes, and Unending Controversy.Seminars in ophthalmology · 2025Review
- Article
- Predicting Malignant Transformation of Choroidal Nevi Using Machine Learning.Research square · 2023Article
- Growth rate of indeterminate choroidal lesions prior to melanoma diagnosis.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2023Article
- A Prediction Model to Discriminate Small Choroidal Melanoma from Choroidal Nevus.Ocular oncology and pathology · 2022Article
- Small Choroidal Melanoma: Correlation between Clinical Characteristics and Metastatic Potential.Ocular oncology and pathology · 2021Article
- A Word of Caution regarding Risk Factors for Malignant Transformation of Choroidal Nevi.Ocular oncology and pathology · 2021Article
- Growth of indeterminate choroidal melanocytic tumors: Time to malignant transformation.Taiwan journal of ophthalmologyReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe aim of the study was to evaluate equivalence of growth rate and pathologic confirmation in small choroidal melanoma (SCM).
designThis study is a case series. SUBJECTS PARTICIPANTS AND CONTROLS: A total of 61 patients with a choroidal melanocytic tumor of size 5.0-16.0 mm in the largest basal diameter and 1.0-2.5 mm in thickness were classified into the pathology-confirmed group (
methodsDistribution of clinical variables (age, gender, laterality, tumor dimensions, tumor location, and presence of orange pigment, subretinal fluid, drusen, and retinal pigment epithelial [RPE] atrophy) between the groups was analyzed. Patient and disease characteristics were summarized as the median and interquartile range for continuous variables and the frequency and percentage for categorical variables. Comparisons were made using the Wilcoxon rank sum test for continuous variables and either Fisher's exact test or the χ
main outcome measuresThe primary aim of this study was to test the hypothesis that "growth" was diagnostic of SCM with the secondary aim of quantifying the malignant "growth rate" (growth rate of SCM).
resultsThe clinical characteristics among all 3 groups were similar except more patients with symptoms (68 vs. 20 vs. 42%, CONCLUSIONS AND RELEVANCE: Choroidal melanocytic lesions exhibiting a defined growth rate can be clinically diagnosed as SCM without a need for biopsy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.